| Date Filed | Type | Description |
| 10/04/2023 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 4,444 shares
@ $11.079, valued at
$49.2k
Sold 1,600 shares
@ $11.7075, valued at
$18.7k
|
|
| 10/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/16/2023 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 6,044 shares
@ $13.0268, valued at
$78.7k
|
|
| 08/15/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 08/03/2023 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 6,044 shares
@ $13.3548, valued at
$80.7k
|
|
| 08/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/17/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 07/06/2023 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 6,044 shares
@ $12.3107, valued at
$74.4k
|
|
| 07/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/16/2023 |
4
| Crowley John F (Director) has filed a Form 4 on Intellia Therapeutics, Inc.|
Txns:
| Granted 4,425 shares
@ $0
Granted 6,473 options to buy
@ $45.2, valued at
$292.6k
|
|
| 06/12/2023 |
4
| Crowley John F (Director) has filed a Form 4 on Entrada Therapeutics, Inc.|
Txns:
| Granted 16,000 options to buy
@ $14.67, valued at
$234.7k
|
|
| 06/05/2023 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 6,044 shares
@ $11.3596, valued at
$68.7k
|
|
| 06/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/17/2023 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 6,044 shares
@ $11.1808, valued at
$67.6k
|
|
| 05/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2023 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 6,044 shares
@ $11.2156, valued at
$67.8k
|
|
| 03/17/2023 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 6,044 shares
@ $11.3414, valued at
$68.5k
|
|
| 02/03/2023 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 147,316 shares
@ $13.1102, valued at
$1.9M
Exercised 83,333 options to buy
@ $6.1, valued at
$508.3k
Exercised 56,596 options to buy
@ $5.13, valued at
$290.3k
|
|
| 01/13/2023 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Granted 210,088 shares
@ $0
Paid exercise price by delivering 83,261 shares
@ $12.02, valued at
$1M
|
|
| 01/11/2023 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 85,102 shares
@ $11.4328, valued at
$973k
|
|
| 01/06/2023 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 10,659 shares
@ $12.03, valued at
$128.2k
|
|
| 01/04/2023 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 21,596 shares
@ $12.21, valued at
$263.7k
Paid exercise price by delivering 22,116 shares
@ $11.93, valued at
$263.8k
Granted 233,248 shares
@ $0
Granted 414,025 options to buy
@ $11.93, valued at
$4.9M
|
|
| 12/19/2022 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 10,468 shares
@ $12.1486, valued at
$127.2k
|
|
| 12/05/2022 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 11,347 shares
@ $12.2035, valued at
$138.5k
|
|
| 11/17/2022 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 10,468 shares
@ $11.6418, valued at
$121.9k
|
|
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2022 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 11,346 shares
@ $10.7462, valued at
$121.9k
|
|
| 09/19/2022 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 10,468 shares
@ $10.6637, valued at
$111.6k
|
|
| 09/06/2022 |
4
| Crowley John F (Executive Chairman) has filed a Form 4 on AMICUS THERAPEUTICS, INC.|
Txns:
| Sold 11,346 shares
@ $11.2958, valued at
$128.2k
|
|
| 08/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|